Stocks

The table gives an overview of all stocks, alphabetically sorted.
 C Security CSEC Dec 13, 2019 0.39 -3.96   
 C-RAD B CRADB Dec 13, 2019 41.45 +0.61   
 CAG Group CAG Dec 13, 2019 63.50 +2.42   
 Calliditas Therapeutics CALTX Dec 13, 2019 70.10 -1.96   
 Calmark B CALMAB Dec 13, 2019 4.51 -4.85   
 Camanio Care CARE Dec 13, 2019 0.28 -9.39   
 Camurus CAMX Dec 13, 2019 81.30 -0.73   
 Cantargia CANTA Dec 13, 2019 20.65 -3.28   
 Capacent Holding CAPAC Dec 13, 2019 39.00 +0.26   
 Carbiotix CRBX Dec 13, 2019 5.92 0.00   
 Castellum CAST Dec 13, 2019 205.50 -1.11   
 Catella A CATA Dec 13, 2019 28.00 0.00   
 Catella B CATB Dec 13, 2019 25.50 -0.20   
 Catena CATE Dec 13, 2019 396.50 -1.12   
 Catena Media CTM Dec 13, 2019 38.80 +0.41   
 Cavotec SA CCC Dec 13, 2019 18.00 -0.83   
 Cell Impact B CIB Dec 13, 2019 8.80 -0.68   
 CellaVision CEVI Dec 13, 2019 315.00 +1.61   
 CELLINK B CLNKB Dec 13, 2019 345.00 +2.68   
 Cereno Scientific B CRNOB Dec 13, 2019 3.60 -1.91   
 CGit B CGITB Dec 13, 2019 35.00 +4.17   
 Challenger Mobile B CHALB Dec 13, 2019 0.04 -18.37   
 Chordate Medical Holding CMH Dec 13, 2019 0.85 +3.66   
 Christian Berner Tech Trade B CBTTB Dec 13, 2019 28.00 +1.45   
 ChromoGenics CHRO Dec 13, 2019 0.47 -0.21   
 Cibus Nordic Real Estate CIBUS Dec 13, 2019 143.00 -1.38   
 Cimco Marine CIMCO Dec 13, 2019 1.51 +1.34   
 Clas Ohlson B CLASB Dec 13, 2019 112.50 -0.44   
 Clavister Holding CLAV Dec 13, 2019 17.70 +4.42   
 Clean Motion CLEMO Dec 13, 2019 1.48 +3.87   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK